New drug donanemab slows cognitive decline in early Alzheimer’s
A drug called donanemab has been shown to slow cognitive decline by 35 per cent in people with early Alzheimer’s disease. However, there has been […]
New drug donanemab slows cognitive decline in early Alzheimer’s Read More »











